Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways.
Kristian ReichJ L K ReichT M FalkN Blödorn-SchlichtUlrich MrowietzR von KiedrowskiC PfeifferJ NiesmannY FrambachR B WarrenPublished in: The British journal of dermatology (2019)